BG

Bellevue Group Portfolio holdings

AUM $5.28B
1-Year Est. Return 50.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+50.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
166
New
Increased
Reduced
Closed

Top Buys

1
+$32.4M
2
+$23.7M
3
+$21.4M
4
HUM icon
Humana
HUM
+$20.1M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$12.1M

Top Sells

1
+$72.3M
2
+$64.4M
3
+$33M
4
CRL icon
Charles River Laboratories
CRL
+$17.5M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15.8M

Sector Composition

1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$19.6K ﹤0.01%
1,130
152
$18.9K ﹤0.01%
2,698
153
$1.96K ﹤0.01%
1,089
154
$165 ﹤0.01%
135
155
– –
-47,681
156
– –
-20,700
157
– –
-213,434
158
– –
-44,050
159
– –
-45,000
160
– –
-18,000
161
– –
-1,000
162
– –
-55,600
163
– –
-286,284
164
– –
-33,000
165
– –
-2,573
166
– –
-18,200
3 4 5 6
7